Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma
Clinical trial NCT01950273 · COMPLETED
Trial details
- NCT number
- NCT01950273
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-27
- Primary completion
- 2015-12-22
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.